Vanda Pharmaceuticals Inc.
-
Ticker
VNDA
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Washington, D.C. United States
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults.
REPORT RATINGS
4.8 / 5.0 (203)
Vanda Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 203 reviews.
Vanda Pharmaceuticals Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports